Molecular Assemblies

Molecular Assemblies is a San Diego-based company developing a revolutionary, enzymatic DNA synthesis technology capable of powering new products in industrial synthetic biology, personalized therapeutics, precision diagnostics, and eventually information storage, nanotechnology and more. Inspired by nature, the company’s proprietary DNA synthesis method is designed to produce long, high quality, sequence-specific DNA reliably, affordably and sustainably. With a highly experienced executive and scientific team and an expansive intellectual property portfolio, Molecular Assemblies has attracted investments from Agilent Technologies, Cavendish Impact Capital Fund, Data Collective Venture Capital, Eleven Two Capital, Genomics Investment Syndicate, Keshif Ventures, Newport Holdings, LP, and Alexandria Venture Investments.

Molecular Assemblies headquartered in United States, North America, operates in the Biotechnology, Health Care, Genetics sector. The company focuses on Biotechnology and has secured $9.4B in funding across 108 round(s). With a team of 1-10 employees, Molecular Assemblies is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - Molecular Assemblies, raised $2.3M. Discover more about their projects, partnerships, and impact on our platform.